Akebia Therapeutics (AKBA) Ownership - Who Owns Akebia Therapeutics?

1,639 Followers

Akebia Therapeutics (AKBA) Ownership Overview

2.85% Insiders

8.76% Mutual Funds

2.73% Other Institutional Investors

12.87% ETFs

72.78% Public Companies and

Individual Investors

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 24.36% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 72.78% is owned by Public Companies and Individual Investors.

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 11.50% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 12.87% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 05, 2026	John P. Butler	xxxxxxxxxxxxx	$86588

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Royce & Associates Llc	xxxxxxxxxxxxx	$39438
Dec 31, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$345209
Dec 31, 2023	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$280431

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
13,110,133	Institution	4.89%	13,241,234
10,795,143	Institution	4.02%	10,903,094
9,774,152	Institution	3.64%	9,871,894
6,934,585	Institution	2.59%	7,003,931
3,526,992	Insider	1.31%	3,562,262
2,764,213	Institution	1.03%	2,791,855
2,623,743	Institution	0.98%	2,649,980
1,460,430	Institution	0.54%	1,475,034
1,282,771	Institution	0.48%	1,295,599
1,225,954	Institution	0.46%	1,238,214

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
10,795,143	Institution	4.02%	10,903,094
2,764,213	Institution	1.03%	2,791,855
2,623,743	Institution	0.98%	2,649,980
1,460,430	Institution	0.54%	1,475,034
757,990	Institution	0.28%	765,570
746,039	Institution	0.28%	753,499
720,848	Institution	0.27%	728,056
534,187	Institution	0.20%	539,529
501,389	Institution	0.19%	506,403
396,648	Institution	0.15%	400,614

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	7,912,283	Institution	2.95%	10,998,073
SPDR S&P BIOTECH ETF	6,511,361	Institution	2.43%	7,488,065
iShares Russell 2000 ETF	5,935,045	Institution	2.21%	7,003,353
Vanguard Extended Market ETF	2,982,409	Institution	1.11%	4,145,549
iShares Russell 2000 Value ETF	1,978,270	Institution	0.74%	2,334,359
Schwab U.S. Small-Cap ETF	1,282,771	Institution	0.48%	1,475,187
Vanguard Russell 2000 ETF	1,243,427	Institution	0.46%	1,728,364
Fidelity Enhanced Small Cap ETF	1,225,858	Institution	0.46%	1,409,737
Vanguard Health Care ETF	754,944	Institution	0.28%	1,049,372
iShares Micro-Cap ETF	643,554	Institution	0.24%	759,394

FAQ

Who Owns Akebia Therapeutics (AKBA)?

According to the latest TipRanks data, approximately 2.73% of the company's stock is held by institutional investors, 2.85% is held by insiders, and 72.78% is held by retail investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by institutional investors?

According to the latest TipRanks data, approximately 2.73% of Akebia Therapeutics (AKBA) stock is held by institutional investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by retail investors?

According to the latest TipRanks data, approximately 72.78% of Akebia Therapeutics (AKBA) stock is held by retail investors.

Who owns the most shares of Akebia Therapeutics (AKBA)?

Vanguard owns the most shares of Akebia Therapeutics (AKBA).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.